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Mutation in the huntingtin (HTT ) gene causes Huntington’s disease (HD). It is an
autosomal dominant trinucleotide-repeat expansion disease in which CAG repeat
sequence expands to >35. This results in the production of mutant HTT protein with an
increased stretch of glutamines near the N-terminus. The wild type HTT gene encodes a
350 kD protein whose function remains elusive. Mutant HTT protein has been implicated
in transcription, axonal transport, cytoskeletal structure/function, signal transduction,
and autophagy. HD is characterized by the appearance of nuclear inclusions and
degeneration of the striatum. Although HTT protein is expressed early in embryos,
most patients develop symptoms in mid-life. It is also unclear why the ubiquitously
expressed mutant HTT specifically causes striatal atrophy. Wild type Htt is essential
for development as Htt knockout mice die at day E7.5. Increasing evidence suggests
mutant Htt may alter neurogenesis and development of striatal neurons resulting in
neuronal loss. Using a mouse embryonic stem cell model, we examined the role of Htt
in neural differentiation. We found cells lacking Htt inefficient in generating neural stem
cells. In contrast differentiation into progenitors of mesoderm and endoderm lineages
was not affected. The data suggests Htt is essential for neural but not cardiac/pancreatic
progenitor differentiation of embryonic stem cells in vitro.
Keywords: Huntington’s disease, huntingtin gene, embryonic stem cells, neural differentiation, embryoid bodies,
neural stem cells
INTRODUCTION
Human HTT is a large protein of approximately 350 kDa made up of 3144 amino acids. It is nearly
ubiquitously expressed with the highest level of expression in the brain and the testes. The size and
predicted structure of the protein suggest its role as a protein scaffold that coordinates a multitude
of cellular functions (reviewed in Saudou and Humbert, 2016). Studies have reported pro-survival
properties of wild type Htt. It protects cells from cell death induced by a variety of stimuli including
serum withdrawal (Rigamonti et al., 2000), mutant Htt (Leavitt et al., 2001), and NMDA receptor-
mediated excitotoxicity (Leavitt et al., 2006). Htt has effects on gene transcription by binding
Abbreviations: EBs, embryoid bodies; GFAP, glial fibrillary acidic protein; HD, Huntington’s disease; Htt, huntingtin; ITSFn,
insulin/transferrin/selenium/fibronectin; Kdm6a, lysine-specific demethylase 6A; MaoA, monoamine oxidase A; mESCs,
mouse embryonic stem cells; NSCs, neural stem cells; PRC, polycomb repressive complex.
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to transcriptional regulators such as the repressor RE1-silencing
transcription factor (Zuccato et al., 2003), p53 and CREB-
binding protein (Steffan et al., 2000), NeuroD (Marcora et al.,
2003), NF-κB (Takano and Gusella, 2002) and transcriptional
activator Sp1 and co-activator TAFII130 (Dunah et al., 2002).
Htt is involved in transport of a variety of vesicles including
brain-derived neurotrophic factor-containing vesicles (Gauthier
et al., 2004), synaptic precursor vesicles (Zala et al., 2013), and
GABA receptor-containing vesicles (Twelvetrees et al., 2010). Htt
coordinates cell division through the regulation of spindle pole
assembly during mitosis (Godin et al., 2010; Elias et al., 2014).
Moreover, Htt is reported involved in ciliogenesis (Keryer et al.,
2011), endosomal trafficking (Pal et al., 2006), and autophagy
(Kegel et al., 2000; Ravikumar et al., 2004).
Wild type Htt is essential for embryonic development as
knockout of Htt in mice results in embryonic death at day 7.5
(Duyao et al., 1995; Nasir et al., 1995; Zeitlin et al., 1995). Htt may
be needed for neurogenesis as reduced expression of wild type
Htt causes impaired brain development and abnormal vascular
morphogenesis in mice (White et al., 1997). Others reported
cells without Htt can be differentiated into functional neurons
(Metzler et al., 1999) or glial cells (Conforti et al., 2013). Thus,
Htt’s role in neural development remains unclear.
Abnormal neurogenesis has been observed in HD. Increased
cell proliferation and neurogenesis were found in human
postmortem HD brains (Curtis et al., 2003), and in the
quinolinic acid lesion rat model of HD (Tattersfield et al., 2004).
Similarly, mutant Htt caused faster neuronal differentiation of
embryonic and NSCs in vitro (Lorincz and Zawistowski, 2009).
In contrast, reduced hippocampal neurogenesis was observed in
R6/2 transgenic HD mice (Gil et al., 2005). Increasing evidence
suggests mutant Htt causes dysregulated neurogenesis. In the HD
R6/2 mice, expansion of striatal NSCs and altered migration of
neural progenitor cells into the striatum were observed (Batista
et al., 2006). A study reported that Q111 Htt knock-in mice
(with glutamine repeats expanded to 111) exhibited defects in
specification and maturation of striatal medium spiny neurons
(Molero et al., 2009). Mutant Htt was also shown to affect cortical
development by causing spindle misorientation in dividing
cortical progenitors (Molina-Calavita et al., 2014). Selective
expression of mutant Htt in mice up to postnatal day 21 resulted
in impairment similar to mice expressing mutant Htt throughout
life (Molero et al., 2016). Furthermore, mice expressing very
low levels of Htt up to postnatal day 21 also exhibited late-
life neurodegeneration phenotypes (Arteaga-Bracho et al., 2016).
These studies suggest developmental abnormalities resulting
from early mutant Htt expression or very low Htt expression may
contribute to the pathogenesis of HD.
Neural stem cells derived from HD mice, or ES cells
expressing mutant Htt or no Htt (Htt-null) have been studied
for growth, motility, and biochemical properties (Ritch et al.,
2012). Interestingly, NS cells derived from HD mouse brains
showed reduced levels of cholesterol, increased reactive oxygen
species, and impaired motility compared with NS cells from wild
type animals, recapitulating phenotypes seen in HD patients.
In contrast, Htt knockout (KO) NS cells derived from Htt-KO
ES cells had increased cholesterol levels. Nguyen et al. used
a neural induction culture model to examine stages of neural
induction in ESCs expressing mutant Htt or in Htt-KO ESCs
(Nguyen et al., 2013a). They reported disruption of proliferation,
self-renewal, and the specification of NSCs in Htt-KO cells
while mutant Htt enhanced neurogenesis. Htt-KO NSCs also
showed increased endodermal and mesodermal gene expression
suggesting Htt may be involved in neural and non-neural fate
decisions. The same group also examined lineage differentiation
of Htt-KO ESCs and ESCs expressing mutant Htt (Nguyen et al.,
2013b). They found Htt required in the differentiation of ESCs
into ectoderm, endoderm, and mesoderm while mutant Htt
differentially impaired stage-specific developmental events.
Recent investigations on how mutant Htt affects neural
development as well as the role of wild type Htt in neural
development suggest neurodegeneration may result from both
gain of toxic mutant Htt function and loss of wild type Htt
function. In this study, we used the 5-stage differentiation
protocol (Schroeder et al., 2009) to differentiate mouse ESCs
lacking Htt to different cell lineages and examined the role of Htt
in progenitor cell differentiation. We found Htt is required for
ectoderm, but not mesoderm or endoderm differentiation under
our experimental conditions.
MATERIALS AND METHODS
Mouse Embryonic Stem Cell Culture
Four mESC lines used in this study are generous gifts of Dr.
Scott O. Zeitlin (University of Virginia). They are: (1) R1,
parental wild type ES cells; (2) Htt-null (HN), Htt nullizygous
ES cells in which the promoter and exon 1 sequence of Htt were
deleted (Zeitlin et al., 1995); (3) 7Q, 3xFlag-Htt7Q/7Q ES cells
that express wild type Htt Flag-tagged at the N-terminus; (4)
140Q, heterozygous 3xFlag-Htt140Q/7Q ES cells carrying an Htt
allele with an expanded polyQ tagged with a 3xFLAG tag at the
N-terminus (Zheng et al., 2012).
Mouse embryonic stem cells were maintained undifferentiated
on 0.1% gelatin-coated plates under feeder-free culture
conditions in standard ES medium containing Dulbecco’s
minimal essential medium (DMEM, Cellgro) supplemented
with 15% ES-Cult FBS (STEMCELL Technologies), 1X
Penicillin–Streptomycin–Glutamine (P/S/Q), 1 mM sodium
pyruvate, 1X non-essential amino acids (NEAA), and 0.1 mM
β-mercaptoethanol (all from GIBCO), 103 Units/ml ESGRO
mouse Leukemia Inhibitory Factor (LIF, Millipore), and 2 µM SU
5402 (VEGFR and FGFR inhibitor; Tocris Bioscience), 0.8 µM
PD184352, and 3 µM CHIR99021 (MEK and GSK3 inhibitors,
respectively, both from BioVision). Standard ES medium was
changed daily and cells were passaged every 2–3 days using
0.05% Trypsin/EDTA.
5-Stage Neural Cell Differentiation
Mouse embryonic stem cells were differentiated into neural cells
according to the 5-stage neural differentiation protocol developed
by Dr. Ronald D.G. McKay (Okabe et al., 1996; Lee et al., 2000).
Undifferentiated ES cells (Stage 1) were grown as described above
for at least three passages before proceeding to the next stage.
Frontiers in Cellular Neuroscience | www.frontiersin.org 2 February 2017 | Volume 11 | Article 33
fncel-11-00033 February 17, 2017 Time: 18:4 # 3
Yu and Tanese Huntingtin Is Required for Neural Progenitor Differentiation
To induce EBs formation (Stage 2), mESCs were dissociated
into single-cell suspension with 0.05% trypsin/EDTA and plated
onto 100 mm non-adherent bacterial petri dishes (2 × 106
cells per dish) in the standard ES medium without LIF and the
inhibitors. Floating EBs formed spontaneously were cultured for
4 days in suspension, collected and plated onto 100 mm tissue
culture plates in the standard ES medium without LIF and the
inhibitors.
After EBs attached to the culture plate began to differentiate
(after 24 h), selection of nestin-positive cells (Stage 3) was
initiated by replacing the standard ES medium with the serum-
free ITSFn medium, which contained DMEM/Ham’s F-12
50/50 (Cellgro) supplemented with 1X P/S/Q, 5 µg/ml insulin,
50 µg/ml human apo-transferrin, 30 nM selenium chloride,
and 5 µg/ml fibronectin. ITSFn medium was replenished every
2 days.
After 8 days of selection, expansion of nestin-positive
cells (Stage 4) was initiated. Briefly, cells were dissociated
with 0.05% trypsin/EDTA and plated on poly-L-ornithine and
laminin-coated tissue culture plates or glass coverslips at a
density of 1.5–2 × 105 cells per cm2 in the N2 medium
containing DMEM/Ham’s F-12 50/50 supplemented with 1X
P/S/Q, 25µg/ml insulin, 50µg/ml human apo-transferrin, 30 nM
selenium chloride, 20 nM progesterone, 100 µM putrescine,
10 ng/ml bFGF (R&D Systems), and 1 µg/ml laminin. Nestin-
positive cells were expanded for 6 days. The medium was changed
every 2 days.
Differentiation (Stage 5) was induced by withdrawing bFGF
from the N2 medium. Cells were incubated under differentiation
conditions for 6–15 days, changing the medium every 2 days.
Alkaline Phosphatase Staining
Alkaline phosphatase staining was used to confirm
undifferentiated mESCs. Cells cultured on 6-well plates
were fixed in a fixative solution (citrate buffered acetone, 60%)
for 30 s, and rinsed gently in deionized water. Cells were
incubated in an alkaline-dye mixture, which contained Fast
Blue RR Salt and Naphthol AS-MX Phosphate Alkaline Solution
(Sigma-Aldrich) for 30 min at 37◦C. Afterward, cells were rinsed
thoroughly in deionized water, followed by examination under a
microscope.
Immunocytochemistry
Cells cultured on glass coverslips were fixed in 4%
paraformaldehyde in PBS for 10 min, followed by
permeabilization in PBS containing 0.25% Triton X-100 for
10 min. Blocking was carried out by incubation in 1% BSA in
PBST (PBS + 0.1% Tween 20) for 30 min. Cells were incubated
with primary antibodies for 2 h at room temperature. Following
antibodies were used at indicated dilutions: mouse α-nestin
(Millipore; 1:300), mouse α-β-III tubulin (Millipore; 1:400) and
rabbit α-GFAP (Sigma-Aldrich; 1:400). Fluorescently labeled
goat α-mouse/rabbit secondary antibody (1:500 for 1 h at
room temperature) was applied to samples in the dark. Nuclear
counterstaining was performed by incubating samples in 1 mM
TO-PRO-3 (Invitrogen) in PBS for 20 min followed by confocal
imaging.
Three Germ Layer Differentiation via
Hanging-Drop EB Formation
Htt mESC lines were induced to differentiate into three germ
layers (ectoderm, mesoderm, and endoderm). Differentiation
protocols used involved hanging-drop EB formation (Schroeder
et al., 2009) in which a defined number of mESCs was used
to form one EB. In this way, all EBs generated would be
of similar size. To make hanging-drop EBs, mESCs were
maintained undifferentiated for at least three passages, followed
by trypsinization and counting. Single-cell suspension containing
defined mESC number (200, 500, and 600 cells/20 µl for
neural, cardiac, and pancreatic differentiation, respectively) was
prepared in the Differentiation Medium I consisting of Iscove’s
modification of DMEM (IMDM) supplemented with 20% ES-
Cult FBS, 1X P/S/Q, 1 mM sodium pyruvate, 1X NEAA and
450 µM monothioglycerol (Sigma-Aldrich). On the lid of a
100 mm bacteriological Petri dish, about 60 droplets (20 µl
per drop) of mESC suspension were placed. 10 ml of PBS was
added to the dish. The lid was inverted and mESCs in hanging-
drops were cultivated for 2–3 days. During this period, mESCs
aggregated to form one EB within each droplet. Hanging-drop
EBs were then incubated in suspension in the Differentiation
Medium I for 2–3 days until the time of specific lineage
differentiation. When collecting or transferring floating EBs,
large orifice 200 µl tips were used to keep EBs intact.
Neural Progenitor Cell Differentiation
Neural EBs (200 mESCs per drop) were hung for 2 days before
transferring to ultra-low attachment 96-well plate and EBs were
further cultivated for 3 days. One EB was placed in one well so
that size and morphology could be examined under a microscope.
Day 5 EBs were collected and placed into a 24-well cell culture
plate for attachment. After 1 day, NSC selection was started
by switching the medium to ITSFn medium, followed by NSC
expansion in the N2 medium. This corresponds to Stage 3 and
Stage 4 of the 5-stage neural differentiation method described
above.
Cardiac Progenitor Differentiation
Cardiac EBs (500 mESCs per drop) were hung for 3 days before
transferring to a 60 mm bacteriological Petri dish and cultured
for 2 days in suspension. Day 5 EBs were placed in gelatin-
coated 6-well plates (about 15 EBs per well) for attachment and
differentiation in Differentiation Medium I. This was sufficient to
drive cardiac differentiation as beating EBs were observed from
both R1 and HN after 7 days. The medium was changed every
2 days for 2 weeks (Boheler et al., 2002; Schroeder et al., 2009).
Pancreatic Progenitor Differentiation
Pancreatic EBs (600 mESCs per drop) were hung for 3 days
before transferring to a 60 mm bacteriological Petri dish
and cultured for 2 days in suspension. Day 5 EBs were
plated on gelatin-coated 6-well plates for attachment and
differentiation in Differentiation Medium I. The medium was
changed every 2 days for 9 days. Cells were trypsinized
and seeded onto poly-L-ornithine/laminin-coated plates in the
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pancreatic differentiation medium. The medium was composed
of DMEM/F12 supplemented with 1X P/S/Q, 25 µg/ml insulin,
50 µg/ml human apo-transferrin, 30 nM selenium chloride,
20 nM progesterone, 100 µM putrescine, 1 µg/ml laminin, 2%
B27 and 10 mM nicotinamide. The medium was changed every
2 days for 3 weeks (Blyszczuk et al., 2004; Schroeder et al., 2009).
In lineage differentiation experiments, cell morphology was
monitored under a microscope throughout the differentiation
protocol. Cells at different stages were collected for RNA
extraction and progenitor-specific markers were detected by
RT-PCR.
RNA Extraction, cDNA Synthesis,
RT-PCR
Total RNA was extracted using TRI-Reagent (Sigma-Aldrich)
followed by DNase-I treatment (Promega). For each sample,
1 µg of total RNA was used to synthesize cDNA using the
First-Strand cDNA Synthesis Kit and 10X primer mix from USB
(Affymetrix). qPCR was carried out on equal volumes of RT
reactions using the 2X SYBR R© Green PCR Master Mix (Applied
Biosystems). Cycling parameters used were: denaturation at
95◦C for 30 s, annealing at 52–60◦C for 40 s depending
on primers, and elongation at 72◦C for 45 s, for 45 cycles.
qPCR data was calculated after normalization to GAPDH
or 18S ribosomal RNA. Primer sequences are provided in
Supplementary Table 1.
Western Blot Analysis
Mouse embryonic stem cells were lysed in total lysis buffer
[20 mM Tris-HCl (pH 8.0), 137 mM NaCl, 1 mM EDTA,
1% Triton X-100, 10% glycerol, 1.5 mM MgCl2, 1 mM DTT,
1 mM PMSF, and 1X protease inhibitor cocktail] and cell lysate
extracted by centrifugation at 13,000 rpm for 30 min at 4◦C.
Protein concentrations were measured by Bradford assay (Bio-
Rad). Fifty micrograms of total protein was loaded in each lane of
an SDS-polyacrylamide gel.
Cytoplasmic and nuclear fractions were extracted using NE-
PER Nuclear and Cytoplasmic Extraction Reagents (Pierce
Biotechnology). From 20 µl of packed cells as starting material,
about 200 µl of cytoplasmic fraction and 100 µl of nuclear
fraction were obtained. Five percentage of total volume was
loaded in each lane.
The following antibodies were used at the indicated
dilution: rabbit α-Kdm6A (1:2000, Bethyl Laboratories),
rabbit α-Olig2 (1:1000, Novus Biologicals), rabbit a-Vinculin
(1:4000, Thermo Fisher Scientific), rabbit α-YY1 (1:2000, Santa
Cruz Biotechnology), IRDye 680RD goat α-rabbit secondary
antibody (1:10000, LI-COR Biosciences). Fluorescent signal was
scanned using the LI-COR Odyssey machine.
Statistical Analysis
Unless stated otherwise, values in the figures and text are
presented as mean ± SEM. Statistical analysis was performed
using Prism 7 (GraphPad Software). One-way analysis of variance
(ANOVA) was used followed by Bartlett’s test. ∗∗∗∗P < 0.0001
represents statistical significance.
RNA-Seq
Total RNA was isolated from three different batches of R1
and HN mESCs collected on different dates using the Direct-
zolTM RNA MiniPrep Kit (Zymo Research) according to the
manufacturer’s instructions. Bioanalyzer was used to determine
RNA concentration and quality. One hundred and thirty
nanograms of total RNA was used to construct RNA-Seq libraries
using Illumina TruSeq RNA Library Preparation Kit v2 and 15
cycles of PCR amplification. Libraries were run on an Illumina
HiSeq 2500 instrument using a paired end 50 protocol, rapid run
flow cell.
Sequencing results were demultiplexed and converted to
FASTQ format using Illumina bcl2fastq software. Reads were
aligned to the mouse genome (build mm10/GRCm38) using the
splice-aware STAR aligner (Dobin et al., 2013). PCR duplicates
were removed using the Picard toolkit1. HTSeq package (Anders
et al., 2015) was utilized to generate counts for each gene based
on how many aligned reads overlap its exons. These counts were
then normalized and used to test for differential expression using
negative binomial generalized linear models implemented by the
DESeq2 R package (Love et al., 2014). Additionally, differential
exon usage analysis was performed using the DEXSeq R package
(Anders et al., 2012). The RNA-seq data has been deposited to the
NCBI GEO database with an accession number GSE92905.
RESULTS
mESCs Lacking Htt Fail to Differentiate
into Neural Stem Cells
We investigated potential role for wild type and mutant Htt in
the differentiation of mESCs to cells of neural lineage. The four
mESC lines tested were: wild type R1 ES cells, Htt nullizygous
HN ES cells (Zeitlin et al., 1995), 7Q ES cells that express Flag-
tagged wild type Htt (3xFlag-Htt7Q/7Q), heterozygous 140Q ES
cells carrying an allele encoding Flag-tagged expanded polyQ Htt
(3xFlag-Htt140Q/7Q) (Zheng et al., 2012). Expression of Htt and
pluripotency markers was verified by immunoblotting and RT-
qPCR (Supplementary Figure 1). The R1, HN, 7Q, and 140Q
ES cells were differentiated into neurons/glia using the 5-stage
neural differentiation method involving generation of massive
EBs (Okabe et al., 1996; Lee et al., 2000). mESCs (Stage 1) were
cultured under feeder-free conditions and undifferentiated status
confirmed by dark purple staining of ES colonies in the AP
assay (Figure 1A). Floating EBs (Stage 2) were spontaneously
generated after seeding mESCs to a non-adherent Petri dish. All
four mESCs formed EBs of different sizes. HN mESCs formed
EBs much smaller than other three lines (Figure 1B). After 4
days in suspension, EBs were transferred to cell culture plates
for attachment and differentiation. This was the start of Stage
3, selection of nestin-positive NSCs. After 1 day in the ITSFn
medium, all EBs from R1, 7Q, and 140Q lines attached and
started to differentiate. However, less than half of HN EBs
attached and showed little signs of differentiation (Figure 1C).
Cells were cultured in ITSFn for seven more days. R1, 7Q, and
1http://broadinstitute.github.io/picard
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FIGURE 1 | Neural differentiation of mESC lines carrying different forms of Htt. Using the 5-stage neural differentiation method, four mESC lines were
differentiated into neurons/glia. Morphology of cells at different stages is shown. (A) Stage 1: mESCs. The pluripotency of mESCs was examined by the AP assay.
(B) Stage 2: floating EBs at Day 3. (C) Stage 3: Selection of NSCs in ITSFn medium. EBs were plated onto cell culture plates for attachment and differentiation.
Morphology of NSCs on Day 1 and Day 8 are shown. The average number of cells collected from one 100 mm dish after Stage 3 (ITSFn, Day 8) for each cell line is
shown in the table. (D) Stage 4: Expansion of nestin-positive NSCs in N2 medium at Day 6. Anti-nestin (green) and TO-PRO-3 dye (blue, nuclei). (E) Stage 5:
Differentiation of neurons/glia at Day 6 (R1, HN, 7Q) and Day 4 (140Q). Shown are β-III tubulin in red, GFAP in green, and TO-PRO-3 in blue. Scale bar: (A–C)
200 µm, (D,E) 25 µm.
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140Q lines continued to differentiate and NSCs spread across the
entire culture plate (Figure 1C, Day 8). After several rounds of
changes of the ITSFn medium over 8 days, only a low percentage
of HN EBs remained attached, with limited differentiation.
Nestin-positive NSCs (Stage 4) were expanded by collecting and
replating the Day 8 ITSFn cells into N2 medium. On average,
nearly 10-fold less cells were obtained from HN (Figure 1C;
Table). After culturing for 6 days in the N2 medium, cells were
stained for an NSC marker nestin. Nearly all differentiated cells
expressed nestin (Figure 1D), indicating successful generation of
NSCs. They were next differentiated into neurons/glia (Stage 5).
A mixture of neurons (β-III tubulin-positive) and glia (GFAP-
positive) was obtained from both R1 and 7Q lines (wild type
for Htt, Figure 1E). Most of HN NSCs died leaving a few
large cells stained positive for GFAP. For 140Q NSCs, cell death
was observed during the final stage of differentiation (Stage 5,
Day 4, Figure 1E; Supplementary Figure 2), consistent with
a previous report (Conforti et al., 2013). In summary, cells
with wild type or mutant Htt (R1, 7Q, and 140Q) were able
to generate NSCs, but cells lacking Htt (HN) did not make
the NSCs. Further, only wild type ES cells differentiated into
neurons/glia.
mESCs Lacking Htt Show Limited
Capacity to Form Neural Progenitor Cells
The above results suggest a requirement for Htt in neural
differentiation. We next employed differentiation protocols
involving hanging-drop EB formation. A defined number of
mESCs was used to form one EB so that all EBs generated
would be of similar size (Schroeder et al., 2009). These protocols
were used to produce progenitors of ectoderm, endoderm, and
mesoderm lineages.
Neural progenitor cell differentiation (ectodermal lineage)
was carried out in four mESC lines (Figure 2A). All made
intact EBs (spheres); however, on average HN neural EBs were
smaller in size (Figure 2B). Instead of using 60 mm Petri
dishes, we modified the original protocol by transferring day 2
neural EBs to ultra low attachment 96-well plates. This way we
could monitor floating EBs one by one under a microscope. For
each EB, it was counted as ‘formed’ if it had a good spherical
structure. The efficiency of EB formation, calculated as the
number of EBs formed over EBs seeded, was similar for all
four cell lines (around 95%, Figure 2B). After culturing in ultra
low attachment 96-well plates for 3 days, bright field images
of Day 5 neural EBs were captured. All EBs generated from
R1, 7Q, and 140Q lines remained spherical, with an average
diameter above 300 µm (Figure 2C). In contrast, HN neural
EBs were much smaller (50% of R1 neural EBs) and appeared
disorganized in structure. Day 5 neural EBs were transferred to
cell culture plates for attachment and differentiation to NSCs
in ITSFn medium. On Day 1 in the ITSFn medium, almost all
R1, 7Q, and 140Q neural EBs attached to cell culture plates and
started to differentiate. However, most HN neural EBs did not
attach. Attached cells if any did not differentiate. Differentiation
potential of neural EBs was calculated as the percentage of
EBs attached and differentiated over the total number of EBs
plated. HN neural EBs showed low efficiency of differentiation
(<10%), while R1, 7Q, and 140Q neural EBs efficiently generated
NSCs (>95%) (Figure 2D). NSC selection in ITSFn medium was
carried out for 8 days. Only a few HN neural EBs attached to
cell culture plates with no sign of differentiation (Figure 2D,
Day 8). In contrast, neural EBs of R1, 7Q, and 140Q cell
lines differentiated into NSCs and occupied nearly the entire
plate.
Quantitative RT-qPCR was performed for Nestin, Pax6, Oct4,
Htt exon 16-17, and GAPDH using RNA collected from cells at
different neural differentiation stages (Figure 2E; Supplementary
Figure 3A). We found expression of Nestin elevated in R1, 7Q,
and 140Q EBs (Day 5) and ITSFn NSCs (Day 8), but not in HN
cells. Lack of Nestin induction in HN ITSFn NSCs agreed with
the observation that HN was less efficient in generating NSCs
compared to stem cells expressing wild type or mutant Htt. We
also examined Pax6 levels during neural differentiation. In ITSFn
NSCs, all four cell lines showed elevated Pax6, however, they were
not statistically significant. At the mESC stage, all four cell lines
showed expression of the pluripotent gene Oct4 (Supplementary
Figure 3A). Upon neural differentiation to EBs and ITSFn NSCs,
Oct4 mRNA levels were dramatically reduced to less than 10%
for R1, 7Q, and 140Q cells. By contrast HN cells maintained
relatively high Oct4 expression in EBs (34%) and ITSFn NSCs
(50%). This is consistent with the observation that HN EBs did
not readily attach and differentiate into NSCs when floating EBs
were placed in cell culture plates. As expected Htt (exon 16-
17) expression in HN cells was 10-fold less than R1, 7Q, and
140Q cells at all stages of differentiation. The results suggest that
HN mESCs have limited capacity in generating neural progenitor
cells.
mESCs Lacking Htt Can Differentiate into
Pancreatic and Cardiac Progenitor Cells
We next sought to determine whether Htt is also required for
endoderm and mesoderm differentiation. Cardiac progenitor
differentiation (mesodermal lineage) was carried out on R1
and HN mESCs using the hanging-drop EB method, with
500 mES cells in each droplet (Figure 3A). At Day 4,
cardiac EBs remained intact in both cell lines, although
the size of HN cardiac EBs was smaller (Figure 3B). On
Day 5, cardiac EBs were transferred to cell culture plates.
Almost all EBs attached and differentiated over the following
2 weeks. Both R1 and HN mESCs differentiated into cardiac
progenitor cells with similar morphology on Day 12 and
Day 19 (Figure 3B). RT-qPCR analysis showed presence
of cardiac progenitor-specific markers Nkx2.5 and αMHC
in differentiated cells (Figure 3C). Interestingly, we found
expression of the markers to be greater at Day 12 in HN
cardiac progenitors compared with Day 19 cells, while R1 cells
showed induction of these two markers as mESCs differentiated
to Day 12 and Day 19 cardiac EBs. The observed difference
suggests Htt may play a limited role in this process. At the
mESC stage, both R1 and HN cells showed expression of
the pluripotent gene Oct4 (Supplementary Figure 3B). Upon
cardiac progenitor cell differentiation, Oct4 mRNA levels were
greatly reduced to about 10% or less in both cell lines.
Immunocytochemistry of Desmin, a specific marker expressed
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FIGURE 2 | Neural progenitor cell differentiation by the hanging-drop EB method (ectodermal lineage). (A) Diagram showing the timeline of neural
progenitor differentiation. (B) Morphology of floating EBs at Day 2. Graph at right shows efficiency of EB formation, calculated as the percentage of EBs
formed over the total number of EBs seeded. R1: 95.62 ± 0.75, HN: 91.04 ± 7.41, 7Q: 94.37 ± 1.71, 140Q: 95.88 ± 2.88. No statistical significance.
(Continued)
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FIGURE 2 | Continued
(C) Morphology and average diameter of Day 5 EBs cultured in ultra low attachment 96-well plate. ∗∗∗∗P < 0.0001, compared to R1, 7Q, and 140Q, by one-way
ANOVA test. n = 3 independent experiments. (D) Generation of NSCs. Morphology of NSCs cultured in ITSFn medium at Day 1 and Day 8. Differentiation potential
of neural EBs was calculated as the percentage of EBs attached and differentiated over the total number of EBs plated. R1: 97.09 ± 4.47, HN: 7.60 ± 12.04, 7Q:
97.08 ± 4.76, 140Q: 95.31 ± 5.86. ∗∗∗∗P < 0.0001, compared to R1, 7Q, and 140Q, by one-way ANOVA test. n = 3 independent experiments. Scale bar (B–D):
200 µm. (E) Expression of different markers during neural progenitor cell differentiation. Quantitative RT-qPCR was performed for Nestin, Pax6, Oct4, Htt exon 16-17,
and GAPDH using RNA collected from cells at different neural differentiation stages including mESC, EB (Day 5), and ITSFn (Day 8). Gene expression was calculated
as fold change (over R1 mESC) after normalization to GAPDH expression. ∗∗∗P < 0.001, compared to mESCs, by Dunnett’s multiple comparisons test (one-way
ANOVA). n.s., non-significant (P > 0.05). Separate graphs for Oct4 and Htt exon 16-17 are shown in Supplementary Figure 3A.
in Day 11 cardiac EBs, showed positive staining in both R1
and HN Day 12 cardiac EBs (Supplementary Figure 4). The
results suggest that Htt is not required for cardiac progenitor
cell differentiation under the experimental conditions used in this
study.
Next, we carried out differentiation of R1 and HN mESCs into
pancreatic progenitor cells (endodermal lineage) (Figure 4A).
Similar to cardiac progenitor differentiation, pancreatic EBs
formed from both cell lines, albeit those from HN EBs were
smaller in size (Figure 4B). We found almost all pancreatic
EBs attach and differentiate after plating Day 5 EBs onto cell
culture plates. Similar morphologies were observed between
R1 and HN differentiated cells (Figure 4B, Day 10). On
Day 14, differentiated cells were collected and replated for
further differentiation into pancreatic progenitors. Both R1 and
HN cell lines gave rise to morphologically similar pancreatic
progenitors as shown for Day 19 and Day 31 (Figure 4B).
Quantitative RT-PCR analysis demonstrated mRNA expression
of Isl1, a marker of pancreatic progenitors, in both R1 and
HN differentiated cells at Day 20 and Day 35 (Figure 4C). Gcg
(glucagon) is a pancreatic hormone whose expression appears
at later stages of pancreatic progenitor cell differentiation.
RT-qPCR data showed induction of Gcg in both R1 and
HN pancreatic EBs after 20 days of differentiation. At Day
15, we observed differences in the levels of Isl1 and Gcg
expression between R1 and HN cells, indicating the absence
of Htt may have an effect on early stages of pancreatic
differentiation. Nestin is also a marker during pancreatic
differentiation. Its expression was found elevated dramatically
in both R1 and HN EBs on Day 15 (>20-fold). Nestin levels
decreased gradually as pancreatic differentiation continued. At
the mESC stage, both R1 and HN cells showed expression of
the pluripotent gene Oct4 (Supplementary Figure 3C). Upon
pancreatic progenitor cell differentiation, Oct4 mRNA levels were
greatly reduced to about 10% in both cell lines. The results
suggest that Htt is also not required for pancreatic progenitor
cell differentiation under the experimental conditions used in this
study.
In these experiments, 500 and 600 mES cells per droplet
were used to generate cardiac and pancreatic EBs, respectively.
Since neural EBs were made with 200 mESCs per droplet we
repeated the experiment with 500 and 1000 mES cells per droplet
(Supplementary Figure 5). We observed HN Day 5 neural EBs
slightly larger when the cell number increased from 500 to 1000
per droplet. However, they remained disorganized similar to
HN neural EBs that were generated from 200 cells per droplet.
Further differentiation in ITSFn medium (Day 1 and Day 6)
showed that HN neural EBs from 500 or 1000 cells per droplet
did not attach and differentiate into NSCs efficiently. Therefore,
increasing the starting number of mESCs to generate neural EBs
did not alter the poor efficiency of Htt-null cells in generating
NSCs.
Transcriptional Profiles of R1 and HN
mESCs by RNA-Seq
The neural differentiation experiments showed inefficient
generation of NSCs from HN mESCs, suggesting Htt plays a
critical role in this process. To investigate the basis for the lack
of neural differentiation we carried out gene expression profiling
by RNA-seq to examine if genes involved in neural differentiation
were dysregulated in HN mESCs.
Using RNA isolated from undifferentiated R1 and HN
mESCs, we performed 50 nucleotide paired-end total mRNA
sequencing. Comparison of expression profiles between HN
and R1 mESCs identified 51 up-regulated genes (log2 fold
change > 1, p < 0.05) and 48 down-regulated genes (log2 fold
change < −1, p < 0.05). Tables 1 and 2 show top 20 up-
regulated and down-regulated genes in HN mESCs. Validation
of the RNA-seq data carried out by RT-qPCR demonstrated
elevated expression of Olig2, Olig1, Nod1, Crisp1, and Sdc2 in
HN mESCs (Figure 5A), while Maoa, Kdm6a, Fundc1, Ly6a,
and Myof mRNA levels were found reduced in HN mESCs
(Figure 5B). Immunoblotting confirmed increased levels of Olig2
protein and reduced levels of Kdm6a protein in the nucleus
(Figure 5C).
We used Gene Set Enrichment Analysis (Mootha et al.,
2003; Subramanian et al., 2005) to compare up-regulated
genes in HN mESCs with curated gene sets within the C2
collection of the Molecular Signatures Database (Subramanian
et al., 2005). We found most enriched signature “Genes
up-regulated in mouse ES cells with deficient SUZ12”
(Table 3). SUZ12 is a component of Polycomb Repressive
Complex 2 (PRC2). Interestingly, Olig2, reported repressed
by PRC1 and PRC2 in mESCs (Boyer et al., 2006), is de-
repressed in HN mESCs (Figure 5A; Table 1). Because there
was a published report suggesting a link between Htt and
components of the PRC2 complex (Seong et al., 2010), we
asked whether Htt repressed the activation of Olig1 and Olig2
genes through the PRC2 complex. We performed chromatin
immunoprecipitation analysis in R1 mESCs and failed to
detect co-occupancy of Htt and Ezh2 (component of PRC2)
at the Olig1 and Olig2 promoter regions (Supplementary
Figure 6).
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FIGURE 3 | Cardiac progenitor cell differentiation by the hanging-drop EB method (mesodermal lineage). (A) Diagram showing the timeline of cardiac
progenitor differentiation. (B) Morphology of R1 and HN cells during cardiac progenitor differentiation. Scale bar: 200 µm. (C) mRNA expression of cardiac
progenitor cell-specific markers αMHC and Nkx2.5 at Day 12 and 19 was determined by quantitative RT-qPCR. Gene expression was calculated as fold change
(over R1 mESC) after normalization to GAPDH expression. ∗∗∗P < 0.001, ∗∗P < 0.01, and ∗P < 0.05, compared to the mESC group by Dunnett’s multiple
comparisons test (one-way ANOVA). Separate graphs for Oct4 and Htt exon 16-17 are shown in Supplementary Figure 3B.
DISCUSSION
Phenotypic Differences between Wild
Type and Mutant Htt in Neural
Differentiation
In this study, we examined a role of Htt in neural differentiation
in vitro using the 5-stage neural differentiation method in four
mESC lines carrying different forms of Htt. Our data show that
Htt is required for neural differentiation of mESCs. Htt is not
needed for mesoderm or endoderm progenitor differentiation.
RNA-seq analysis shows candidate dysregulated genes that
may be involved in the inefficient NSC generation in mESCs
lacking Htt.
Compared to wild type or mutant Htt-expressing cell lines
(R1, 7Q, and 140Q), Htt nullizygous mESCs are not prone
to generating NSCs as shown by small EB size and low
tendency to attach to a plate and differentiate into NSCs. Further
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FIGURE 4 | Pancreatic progenitor cell differentiation by the hanging-drop EB method (endodermal lineage). (A) Diagram showing the timeline of
pancreatic progenitor differentiation. (B) Morphology of R1 and HN cells during pancreatic progenitor differentiation. Scale bar: 200 µm. (C) mRNA expression of
pancreatic progenitor cell-specific marker Isl1 and Gcg at Day 15, 20, and 35 was determined by quantitative RT-qPCR. Gene expression was calculated as fold
change (over R1 mESC) after normalization to GAPDH expression. ∗∗∗∗P < 0.0001, ∗∗∗P < 0.001, ∗∗P < 0.01, and ∗P < 0.05, compared to the mESC group by
Dunnett’s multiple comparisons test (one-way ANOVA). Separate graphs for Oct4 and Htt exon 16-17 are shown in Supplementary Figure 3C.
differentiation of HN NSCs to neurons/glia resulted in massive
cell loss and formation of a few giant GFAP-positive cells. This
observation is consistent with a recent report demonstrating that
absence of Htt in mESCs promotes NSC differentiation into
glial cell fate (Conforti et al., 2013). This conclusion is based
on the increase of GFAP-positive cells at the terminal neuronal
differentiation stage. In their report, both wild type and Htt-null
ES cells generated similar numbers of NSCs. However, our
data show that HN mESCs have limited capacity for generating
NSCs. The discrepancy may be explained by different neural
differentiation protocols used. Conforti et al. (2013) used a
monolayer differentiation method (Spiliotopoulos et al., 2009),
while we adopted the 5-stage neural differentiation protocol
involving EB formation.
In contrast, neural EBs expressing mutant Htt (140Q) attached
more readily to plates and differentiated into NSCs. Further
differentiation of 140Q NSCs into neurons/glia resulted in
cell death. These results agree with studies demonstrating that
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TABLE 1 | Top 20 up-regulated genes in Htt-null mESCs (HN compared with R1).
Gene symbol Gene description log2 fold change p-value p-adj




Nod1 Nucleotide-binding oligomerization domain containing 1 2.120 1.30E-10 8.68E-08
Hist1h2bm Histone cluster 1, H2bm 1.933 2.63E-28 1.85E-24
Olig1 Oligodendrocyte transcription factor 1 1.883 5.60E-09 3.02E-06
Snrpf Small nuclear ribonucleoprotein polypeptide F 1.744 7.25E-18 1.02E-14
Mapt Microtubule-associated protein tau 1.662 3.93E-12 3.44E-09
Sdc2 Syndecan 2 1.575 3.63E-08 1.64E-05
B3galtl Beta-1,3-galactosyltransferase-like 1.555 1.57E-08 7.61E-06
Fam129a Family with sequence similarity 129, member A 1.542 3.10E-10 1.98E-07
Ubd Ubiquitin D 1.472 2.78E-05 5.57E-03
Uggt2 UDP-glucose glycoprotein glucosyltransferase 2 1.468 7.54E-06 1.85E-03
Cd68 CD68 molecule 1.460 7.16E-13 7.18E-10
Peg3 Paternally expressed 3 1.458 5.40E-06 1.43E-03
D2hgdh D-2-hydroxyglutarate dehydrogenase 1.420 7.07E-06 1.77E-03
Fam25c Family with sequence similarity 25, member C 1.412 7.13E-17 9.09E-14
Crisp1 Cysteine-rich secretory protein 1 1.318 1.83E-04 2.54E-02
Tgds TDP-glucose 4,6-dehydratase 1.294 1.28E-05 2.85E-03
Olig2 Oligodendrocyte transcription factor 2 1.281 2.69E-04 3.52E-02
Trim34a Tripartite motif containing 34A 1.253 3.76E-04 4.59E-02
presence of polyQ-expanded Htt increases neural differentiation
of embryonic and NSCs (Lorincz and Zawistowski, 2009), and
cells with mutant polyQ Htt undergo cell death during neuronal
differentiation (Conforti et al., 2013).
Studies by Nguyen et al. (2013b) found Htt-KO ESCs to be
impaired for survival and specification of all three germ layers
during EB formation and under inductive conditions, suggesting
Htt is required for neural and non-neural differentiation. In
contrast, mutant Htt-expressing cells showed alterations in stage-
specific developmental events. The HN ESCs we examined
were defective for differentiation into neural lineage, but not
cardiac or pancreatic lineages. The Htt-KO ESCs used by above
authors are deleted of exons 4 and 5 in the murine Htt gene
(Duyao et al., 1995). The HN ESCs used in this study were
TABLE 2 | Top 20 down-regulated genes in Htt-null mESCs (HN compared with R1).
Gene symbol Gene description log2 fold change p-value p-adj
Maoa Monoamine oxidase A −4.129 6.59E-45 9.25E-41
Kdm6a Lysine (K)-specific demethylase 6A −3.481 5.22E-28 2.40E-24
Fundc1 FUN14 domain containing 1 −3.030 6.62E-21 1.03E-17
Hist1h4i Histone cluster 1, H4i −2.290 1.53E-23 3.07E-20
Tmem64 Transmembrane protein 64 −1.931 5.54E-25 1.30E-21
Khdc3 KH domain containing 3 −1.851 3.43E-11 2.53E-08
Htt Huntingtin −1.838 4.05E-10 2.47E-07
Myof Myoferlin −1.769 5.92E-10 3.46E-07
Hnf4a Hepatocyte nuclear factor 4, alpha −1.705 8.26E-07 2.47E-04
Wdfy1 WD repeat and FYVE domain containing 1 −1.625 5.75E-16 6.72E-13
Sfmbt2 Scm-like with four mbt domains 2 −1.607 1.88E-09 1.05E-06
Pttg1 Pituitary tumor-transforming 1 −1.580 6.37E-09 3.31E-06
Trh Thyrotropin-releasing hormone −1.568 1.08E-12 1.01E-09
Hist1h2bp Histone cluster 1, H2bp −1.537 5.50E-11 3.85E-08
Adam23 ADAM metallopeptidase domain 23 −1.508 7.97E-08 3.27E-05
Atp10d ATPase, class V, type 10D −1.489 1.94E-07 6.96E-05
Anxa3 Annexin A3 −1.399 1.11E-05 2.55E-03
Crxos1 Crx opposite strand transcript 1 −1.350 1.27E-04 1.94E-02
Eras ES cell expressed Ras −1.311 7.58E-08 3.22E-05
Fbxo2 F-box protein 2 −1.289 5.61E-05 9.59E-03
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FIGURE 5 | Differentially expressed genes in R1 and Htt-null mESCs. mRNA levels of genes (A) up-regulated or (B) down-regulated in HN mESCs
compared with R1 cells were confirmed by quantitative RT-qPCR. Gene expression was calculated as relative expression after normalization to18S rRNA. All
experiments were carried out using RNA samples extracted from four different batches of R1 and HN mESCs (N = 4). ∗∗∗∗P < 0.0001, ∗∗P < 0.01, and ∗P < 0.05,
compared to R1, by unpaired t-test. a.u., arbitrary units. (C) Protein levels of Olig2 and Kdm6a were examined by immunoblotting. Vinculin and YY1 served as
markers of cytoplasmic and nuclear fractions, respectively. ∗Kdm6a (170 kD), ∗∗Olig2 (32 kD).
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TABLE 3 | Gene Set Enrichment Analysis finds ES cells with deficient SUZ12 share similar enriched signatures of up-regulated genes with Htt-null
mESCs.
Gene Set Name # Genes in Gene Set (K) Description # Genes in Overlap (k) k/K p-value FDR q-value
PASINI_SUZ12_TARGETS_UP 112 Genes up-regulated in ES (embryonic
stem cells) with deficient SUZ12
[GeneID = 23512].
15 0.1339 9.54E-18 4.51E-14
HTRA1 LAPTM5 NROB1 NFATC2IP C17orf48
SPP1 LAMA1 H19 RPP25 CYCTP
TMEM40 PRDM14 AQP3 C17orf96 TEX15
List of overlapping genes are shown above.
created by deleting the promoter and exon 1 sequence of Htt
(Zeitlin et al., 1995). Our 5-stage differentiation protocol also
differed from the neural induction protocol used by Nguyen
et al. (2013b). These differences may account for the different
outcomes of ESCs undergoing differentiation. At a molecular
level we observed differences in mRNA expression of cardiac
and pancreatic progenitor markers between wild type and Htt-
null cells. Thus, Htt appears to play a role in the pattern of gene
expression through different stages of differentiation of cardiac
and pancreatic progenitors.
Transcriptional Profiling of mESCs
Lacking Htt
The most down regulated gene in Htt null cells is MaoA,
an enzyme that degrades amine neurotransmitters such as
serotonin, dopamine, and noradrenalin. Its deficiency causes
excess production of monoamine neurotransmitters resulting in
enhanced aggressiveness in mice and humans (Brunner et al.,
1993; Alia-Klein et al., 2008). Changes in the dopaminergic
system have been correlated with HD pathogenesis (Chen et al.,
2013; Schwab et al., 2015). Using well characterized immortalized
mouse striatal cell lines STHdhQ7/Q7 and STHdhQ111/Q111, MaoA
expression and activity were found elevated in cells expressing
mutant Q111 Htt (Ooi et al., 2015). STHdhQ111/Q111 cells
also showed enhanced susceptibility to stress and cell death.
Interestingly, a recent study found polymorphisms in the MAOA
gene as modifiers of psychiatric and cognitive symptoms in
HD patients (Vinther-Jensen et al., 2016). MaoA may play a
regulatory role in neural differentiation as mouse ES cells lacking
MaoA show reduced differentiation to neural cells compared
to wild type (Wang et al., 2011). Similar mechanisms may be
responsible for the poor neural differentiation of Htt-null ES cells
reported in this study.
Oligodendrocyte transcription factor 1 and 2 (Olig1 and
Olig2) are basic helix-loop-helix transcription factors that
promote oligodendrocyte specification in early neural progenitor
cells. They were found up regulated in HN cells. It has been
shown that Olig2 is repressed by polycomb repressive complexes
in mESCs (Boyer et al., 2006). In a transgenic mouse model
in which Olig2 was overexpressed in NSCs, severe defects in
brain development and massive neuronal cell death of cortical
progenitors were observed (Liu et al., 2015). Olig2 was shown
to target enhancers of neurogenic genes and inhibit cortical
neurogenesis. A recent mouse study revealed that Brg1, a subunit
of the SWI/SNF chromatin remodeling complex, interacts with
the Olig2 promoter and represses Olig2 expression in the cortex
(Matsumoto et al., 2016). Although Brg1-null neural progenitor
cells show early expression of Olig2 in the cortex, they fail
to differentiate into oligodendrocyte progenitors. These studies
suggest elevated levels of Olig2 in neural progenitor cells cause
dysregulated neurogenesis or neuronal cell death.
A previous study examined gene expression profiles of mESCs
with and without Htt (Strehlow et al., 2007). Microarray analysis
showed diminished expression of vital patterning genes including
Lefty1, Otx2, and Pem (Rhox5), as well as increased lysosomal
activity genes such as Casp8 and Psmd8 in Htt-null mESCs (by
at least twofold). We also found similar expression patterns of
these genes in HN mESCs; however, fold changes were minimal
(less than twofold). Although HN mESCs are the same in both
studies, differences in gene expression profiling may be due to
cell culture conditions and analytical methods used. We adopted
the “3i +mLIF” formula to maintain the pluripotency of mESCs
(Ying et al., 2008). Two additional studies reported RNA profiling
of Htt-null cells by microarray (Jacobsen et al., 2011) and RNA-
seq (Biagioli et al., 2015). We compared our RNA-seq data with
the microarray study; however, we did not find any overlapping
genes dysregulated by at least twofold. As mentioned above an
important difference is that the cell line used in their study was
the Htt-dKO ESCs (exon 4/5 deletion), while the HN ESCs used
in our study were deleted of the promoter and exon 1 sequence.
There may exist subtle molecular differences between the two cell
lines.
We used Gene Set Enrichment Analysis to compare
up-regulated genes in HN ESCs with curated gene sets
in the Molecular Signatures Database. The most enriched
signature was found in the up-regulated genes in mouse
ES cells deficient of SUZ12, a component of the PRC2
repressor complex (Table 3). A link between PRC2 and HD
has been reported. A recent genome-wide ChIP study for
the H3K4me3 histone mark found altered enrichment in
postmortem prefrontal cortex of HD patient samples compared
with control brains (Dong et al., 2015). They also reported
depletion of the PRC2 repressive state in H3K4me3-enriched
peaks in HD, suggesting epigenetic modifications contribute to
Frontiers in Cellular Neuroscience | www.frontiersin.org 13 February 2017 | Volume 11 | Article 33
fncel-11-00033 February 17, 2017 Time: 18:4 # 14
Yu and Tanese Huntingtin Is Required for Neural Progenitor Differentiation
dysregulated gene expression associated with neurodegeneration.
Further, PRC2 deficiency in striatal neurons resulted in
transcriptional changes leading to neurodegeneration in mice
(von Schimmelmann et al., 2016). Although PRC2 has been
shown to be a direct target of Htt (Seong et al., 2010), we did
not detect co-occupancy of Htt and Ezh2 (component of PRC2)
at Olig1 and Olig2 promoter regions. Nevertheless, the finding
that the transcriptional profile of Htt-null ES cells is most similar
to that of cells lacking a PRC2 component lends further support
to the idea that epigenetic gene regulation plays a role in HD
pathogenesis.
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